Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation
1 other identifier
interventional
60
1 country
1
Brief Summary
The main focus of this pilot study is to construct a fairly complete protein profile of the epidermis. This will allow us to study how the epidermis responds to external stressors such as ultra-violet. We hypothesize that by using the cutting edge technology, proteomics, we will be able to construct a fairly complete profile of different epidermal cells (keratinocytes, epidermal nerve fibers (ENFs), melanocytes, Langerhans cell,...etc) of normal and ultraviolet (UV) irradiated skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Feb 2007
Longer than P75 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2006
CompletedFirst Posted
Study publicly available on registry
November 9, 2006
CompletedStudy Start
First participant enrolled
February 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMay 17, 2016
May 1, 2016
4.8 years
November 7, 2006
May 13, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Ability to quantify protein changes at cytoplasmic and membrane protein levels of epidermal cells in normal vs. irradiated skin
1 year
Secondary Outcomes (1)
Obtain a profile of membrane integrated and cytoplasmic proteins of epidermal cell populations which will facilitate our understanding of biological responses to UV irradiation.
1 year
Study Arms (1)
1
EXPERIMENTALComparing irradiated skin to non irradiated skin.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy Males age 18-30
- Caucasian
- No neurological disease
You may not qualify if:
- Use of any medication that affects skin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Study Officials
- PRINCIPAL INVESTIGATOR
George Wilcox, PhD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2006
First Posted
November 9, 2006
Study Start
February 1, 2007
Primary Completion
November 1, 2011
Study Completion
December 1, 2015
Last Updated
May 17, 2016
Record last verified: 2016-05